New study shows promise in reducing surgical risks associated with surgica...( 34 U.S. medical centers across the coun...),Health

34 U.S. medical centers across the country. One group of patients (n=206) was treated with bThrombin and a second group (n=205) was treated with rhThrombin, both of which were applied topically to the bleeding site(s) in combination with an absorbable gelatin sponge. The primary endpoint was the time it took for hemostasis to occur, as measured by the incidence of hemostasis within 10 minutes. Secondary endpoints included the incidence and severity of adverse events and the incidence of antiproduct antibodies.

The study demonstrated that both rhThrombin and bThrombin had comparable efficacy, with 95 percent of patients in each treatment group achieving hemostasis within 10 minutes. The two treatments had similar safety profiles, although antibody development was significantly lower in patients treated with rhThrombin compared with bThrombin (1.5 percent versus 21.5 percent, respectively).

'"/>

Contact: Sally Garneski
pressinquiry@facs.org
312-202-5409
Weber Shandwick Worldwide
10-Aug-2007

Page: 1 2
Related medicine news :

1. Childhood obesity indicates greater risk of school absenteeism, Penn study reveals
2. Penn study finds pro-death proteins required to regulate healthy immune function
3. New study counts the economic cost of persistent pain in Australia
4. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
5. Most seniors now have drug coverage, U-M study shows
6. To gain muscle and lose fat, drink milk: study
7. Wheres the beef? Not enough of it is on elders plates, muscle-metabolism study suggests
8. Even older women at high risk have little interest in being tested for HIV, study finds
9. Metabolic study in mice could lead to good cholesterol boosters
10. Michigan-CDC study supports value of social restrictions during influenza pandemics
11. Old McDonalds has a hold on kids taste buds, Stanford/Packard study finds